Eduardo Collantes
Department of Rheumatology
Reina Sofia University Hospital of Córdoba
Córdoba
Name/email consistency: high
- Effectiveness of reducing infliximab dose interval in non-responder patients with refractory spondyloarthropathies. An open extension of a multicentre study. Collantes-Estevez, E., Muñoz-Villanueva, M.C., Zarco, P., Torre-Alonso, J.C., Gratacós, J., González, C., Sanmartí, R., Cañete, J.D. Rheumatology. (Oxford) (2005)
- Improved control of osteoarthritis pain and self-reported health status in non-responders to celecoxib switched to rofecoxib: results of PAVIA, an open-label post-marketing survey in Spain. Collantes-Estevez, E., Fernandez-Perez, C. Curr. Med. Res. Opin (2003)
- A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273]. Collantes, E., Curtis, S.P., Lee, K.W., Casas, N., McCarthy, T., Melian, A., Zhao, P.L., Rodgers, D.B., McCormick, C.L., Lee, M., Lines, C.R., Gertz, B.J. BMC. Fam. Pract (2002)